pDONR221-SARS-CoV-2-nsp5-C145A
(Plasmid
#247690)
-
PurposeGateway cloning compatible entry vector for SARS-CoV-2 nsp5 with C145A mutation.
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 247690 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepDONR221
-
Vector typeSynthetic Biology
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSARS-CoV-2 3CL protease with C145A
-
SpeciesSARS-CoV-2
-
MutationC145A
Cloning Information
- Cloning method Other
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pDONR221-SARS-CoV-2-nsp5-C145A was a gift from Sho Iketani (Addgene plasmid # 247690 ; http://n2t.net/addgene:247690 ; RRID:Addgene_247690) -
For your References section:
Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors. Chithelen J, Lovett DH, Wang K, Torres Yanagisawa AE, Caccin FNM, Iketani S. Nat Commun. 2026 May 19;17(1):6575. doi: 10.1038/s41467-026-73444-y. 10.1038/s41467-026-73444-y PubMed 42156379